Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers

NCT00767234 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00767234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00767234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers
Lead sponsor
Stanford University
Phase
Observational
Overall status
Terminated
Start date
August 31, 2008
Completion date
October 31, 2011
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, bile duct carcinoma, carcinoma of the large intestine, colon rectal cancer adenocarcinoma, esophageal cancer, gall bladder cancer, gallbladder carcinoma, gastric (stomach) cancer, gastrointestinal neoplasms, gastrointestinal stromal tumor (gist), gastrooesophageal cancer, hepatobiliary neoplasm, liver carcinoma, pancreatic cancer